Products - Hemispherx Biopharma, Inc.

powered by SwissVault data engine

Products - Hemispherx Biopharma, Inc.

Abstract Essence

[of] [to] [the] [or] [FDA] [approval] [Hemispherx] [Alferon] [N] [Injection®] [Ampligen] [treatment] [patients] [Approved] [Launch] [pending] [Products] [Biopharma] [Inc] [CONTACT] [PRODUCT] [NAME] [Country] [CATEGORY] [for] [who] [have] [Treatment] [refractory] [external] [condylomata] [acuminata] [recombinant] [interferon] [COMMERCIAL] [STATUS] [manufacturing] [Terms] [Use] [Skip] [content] [COMPANY] [PRODUCTS] [R] [D] [PARTNERING] [INVESTOR] [RELATIONS] [BLOG] [Commercial] [Rintatolimod] [U] [S] [Tradename] [Ampligen®] [Argentina] [rintatolimod] [sterile] [solution] [is] [indicated] [severely] [debilitated] [with] [chronic] [fatigue] [syndrome] [cfs] [been] [diagnosed] [longer] [than] [one] [year] [recurrent] [initially] [responded] [alfa] [including] [pegylated] [alpha] [but] [that] [subsequently] [failed] [due] [presence] [neutralizing] [antibodies] [intolerance] [these] [treatments] [export] [authorization] [USA] [Intralesional] [recurring] [Sales] [anticipated] [resume]